Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies

The New England Journal of Medicine
R HoffmanV Floyd

Abstract

We have recently described an in vitro clonal assay system for human megakaryocyte-progenitor cells or megakaryocytic colony-forming units (CFU-M). Serum specimens from patients with quantitative platelet disorders were screened for the capacity to alter in vitro megakaryocyte-colony formation. Serum from 11 patients with hypomegakaryocytic thrombocytopenia significantly enhanced the formation of CFU-M-derived colonies (200 to 1840 per cent). Neither serum from eight patients with thrombocytopenia and normal or increased numbers of marrow megakaryocytes nor serum from 11 patients with thrombocytosis altered colony formation. This stimulatory activity has been termed megakaryocytic-colony-stimulating activity (Meg-CSA). The number of megakaryocytic colonies formed was directly proportional to the quantity of stimulatory serum added. Meg-CSA levels appeared to be inversely related to marrow megakaryocyte numbers. The variations in Meg-CSA levels that were detected in different disease states suggest that alterations in the production of this stem-cell regulator have physiologic importance.

References

Sep 11, 1975·The New England Journal of Medicine·H J Weiss
Mar 1, 1978·British Journal of Haematology·J W Adamson, P J Fialkow
Aug 23, 1979·Biochimica Et Biophysica Acta·S L Marchesi, J A Chasis
Aug 12, 1976·The New England Journal of Medicine·R Ross, J A Glomset
May 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·D MetcalfB Sordat
Mar 1, 1976·Proceedings of the Society for Experimental Biology and Medicine·A Nakeff, S Daniels-McQueen
Jan 1, 1974·Annual Review of Medicine·L A Harker
Jun 1, 1969·The Journal of Clinical Investigation·L A Harker, C A Finch
Sep 1, 1969·The Journal of Clinical Investigation·B L Evatt, J Levin
Dec 1, 1950·Journal of Applied Physiology·G BRECHER, E P CRONKITE

❮ Previous
Next ❯

Citations

Feb 25, 1998·Stem Cells·M MuroneF J de Sauvage
Jul 1, 1990·International Journal of Cell Cloning·A M Gewirtz, B Calabretta
Dec 1, 1987·Klinische Wochenschrift·M WinkelmannW Schneider
Apr 1, 1987·Klinische Wochenschrift·L KanzA A Fauser
Jan 1, 1990·Biotherapy·A GrossiP Rossi Ferrini
Nov 13, 2009·Indian Journal of Pediatrics·Jagdish Chandra, V P Choudhry
Aug 1, 1995·Critical Reviews in Oncology/hematology·W VainchenkerF Wendling
Nov 1, 1995·Critical Reviews in Oncology/hematology·G Zauli, L Catani
Jan 19, 2007·The New England Journal of Medicine·Sudhir Tauro
Jun 1, 1993·British Journal of Haematology·C L Erickson-MillerM J Murphy
Jun 1, 1986·Archives of Disease in Childhood·L SirotaM Djaldetti
Apr 1, 1985·The Journal of Clinical Investigation·R HoffmanJ E Straneva
Jun 1, 1986·The Journal of Clinical Investigation·H H YangR Hoffman
Nov 1, 1988·The Journal of Clinical Investigation·M W LongS G Emerson
Mar 16, 2005·International Journal of Hematology·Robert McMillan, Diane Nugent
Apr 1, 1985·The American Journal of the Medical Sciences·R G Sheehan
Sep 29, 2007·Critical Reviews in Oncology/hematology·Lin WangMing Hou
Jan 1, 1985·Critical Reviews in Oncology/hematology·A M Gewirtz, R Hoffman
Jun 1, 1995·The American Journal of Medicine·Z EstrovR Kurzrock
Apr 1, 1991·Thrombosis Research·M Podolak-Dawidziak
Mar 15, 1989·Thrombosis Research·N BasaraV Pavlović-Kentera
Oct 1, 1982·British Journal of Haematology·N Williams, R F Levine
Apr 1, 1986·British Journal of Haematology·M KawakitaK Takatsuki
Oct 1, 1988·British Journal of Haematology·A C HomansE M Mazur
Apr 1, 1984·British Journal of Haematology·G VinciW Vainchenker
May 1, 1989·International Journal of Cell Cloning·T P McDonald
Aug 13, 2002·Hematology·Sema KarakuşSemra V Dündar
Feb 1, 1997·Baillière's Clinical Haematology·J BriereE Peynaud-Debayle
Jan 1, 1990·Nouvelle Revue Française D'hématologie·Z C HanJ P Caen
Jan 1, 1987·Annals of the New York Academy of Sciences·T P McDonald
Jan 1, 1982·Journal of Cellular Physiology. Supplement·H A MessnerC Izaguirre
Jul 1, 1985·Journal of Cellular Physiology·L A SolbergH A Messner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.